Your browser doesn't support javascript.
loading
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.
McFarland, Elizabeth J; Karron, Ruth A; Muresan, Petronella; Cunningham, Coleen K; Valentine, Megan E; Perlowski, Charlotte; Thumar, Bhagvanji; Gnanashanmugam, Devasena; Siberry, George K; Schappell, Elizabeth; Barr, Emily; Rexroad, Vivian; Yogev, Ram; Spector, Stephen A; Aziz, Mariam; Patel, Nehali; Cielo, Mikhaela; Luongo, Cindy; Collins, Peter L; Buchholz, Ursula J.
Affiliation
  • McFarland EJ; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora.
  • Karron RA; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Muresan P; Statistical and Data Analysis Center, Harvard School of Public Health, Boston, Massachusetts.
  • Cunningham CK; Department of Pediatrics, Duke University Medical Center.
  • Valentine ME; FHI 360, Durham, North Carolina.
  • Perlowski C; FHI 360, Durham, North Carolina.
  • Thumar B; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Gnanashanmugam D; Maternal, Adolescent and Pediatric Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda.
  • Siberry GK; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda.
  • Schappell E; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Barr E; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora.
  • Rexroad V; Investigational Drug Service Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland.
  • Yogev R; Department of Pediatrics, Northwestern University Medical School and Ann and Robert H. Lurie Children's Hospital of Chicago, Illinois.
  • Spector SA; Department of Pediatrics, University of California San Diego, La Jolla.
  • Aziz M; Section of Infectious Disease, Rush University Medical Center, Chicago, Illinois.
  • Patel N; Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Cielo M; Division of Infectious Diseases, Maternal Child and Adolescent Center, University of Southern California Keck School of Medicine, Los Angeles.
  • Luongo C; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryl.
  • Collins PL; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryl.
  • Buchholz UJ; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryl.
J Infect Dis ; 217(9): 1347-1355, 2018 04 11.
Article de En | MEDLINE | ID: mdl-29509911

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines virales / Virus respiratoire syncytial humain / Infections à virus respiratoire syncytial / Vaccins contre les virus respiratoires syncytiaux / Anticorps neutralisants Type d'étude: Clinical_trials Limites: Female / Humans / Infant / Male Langue: En Journal: J Infect Dis Année: 2018 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines virales / Virus respiratoire syncytial humain / Infections à virus respiratoire syncytial / Vaccins contre les virus respiratoires syncytiaux / Anticorps neutralisants Type d'étude: Clinical_trials Limites: Female / Humans / Infant / Male Langue: En Journal: J Infect Dis Année: 2018 Type de document: Article